Kinases as Antitargets in Genotoxicity

Polypharmacology in Drug Discovery

Volumn , Issue , 2012, Pages 63-81

  Kirchner, Stephan ^a  

^a F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

CDK inactivation, and cell cycle phase; Kinases as antitargets in genotoxicity; Mitotic kinases

Indexed keywords

EID: 84859269789     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781118098141.ch4     Document Type: Chapter

References (60)

1. De Bondt, H. L.; Rosenblatt, J.; Jancarik J.; Jones, H. D.; Morgan, D. O.; Kim, S. H. (1993), Crystal structure of cyclin-dependent kinase 2, Nature 363, 595-602.
2. Huang, D.; Zhou, T.; Lafleur, K.; Nevado, C.; Caflisch, A. (2010), Kinase selectivity potential for inhibitors targeting the ATP binding site: A network analysis, Bioinformatics 26(2), 198-204.
3. Liu, Y.; Gray, N. S. (2006), Rational design of inhibitors that bind to inactive kinase conformations, Nature Chem. Biol. 2, 358-364.
4. Grimsby, J. et al. (2003), Allosteric activators of glucokinase: Potential role in diabetes therapy, Science 301, 370-373.
5. Cohen, M. S.; Zhang, C.; Shokat, K. M.; Taunton, J. (2005), Structural bioinformaticsbased design of selective, irreversible kinase inhibitors, Science 308, 1318-1321.
6. Kwak, E. L. et al. (2005), Irreversible inhibitors of the EGF receptor may circumvent acquired resistance to gefitinib, Proc. Natl Acad. Sci. USA 102, 7665-7670.
7. Zhang, J.; Yang, P. L.; Gray, N. S. (2009), Targeting cancer with small molecule kinase inhibitors, Nature Rev. Cancer 9(1), 28-39.
8. Borgne, A.; Golsteyn, R. M. (2003), The role of cyclin-dependent kinases in apoptosis, in Meijer, L.; Jézéquel, A.; Roberge, M.; eds. , Progress in Cell Cycle Research, Life in Progress Editions, Roscoff, France, 2003, p. 453.
9. Borgne, A.; Versteege, I.; Mahé, M.; Studeny, A.; Léonce, S.; Naime, I.; Rodriguez, M.; Hickman, J. A.; Meijer, L.; Golsteyn, R. M. (2006), Analysis of cyclin B1 andCDKactivity during apoptosis induced by camptothecin treatmentA role for cyclin B1 in apoptosis, Oncogene 25, 7361-7372.
10. Garriga, J.; Grana, X. (2004), Cellular control of gene expression by T-type cyclin/CDK9 complexes, Gene 337, 15.
11. Loyer, P., Trembley, J. H., Katona, R., Kidd, V. J., Lahti, J. M. (2005), Role of CDK/cyclin complexes in transcription and RNA splicing, Cell Signal. 17, 1033.
12. Cruz, J. C.; Tsai, L. H. (2004), A Jekyll and Hyde kinase: Roles for Cdk5 in brain development and disease, Curr. Opin. Neurobiol. 14, 390.
13. Pareek,T. K.;Keller, J.;Kesavapany, S.; Pant, H. C.; Iadarola, M. J.; Brady,R. O.; Kulkarni, A. B. (2006), Cyclin-dependent kinase 5 activity regulates pain signaling, Proc. Natl. Acad. Sci. USA. 103, 791.
14. Morgan, D. O. (1997), Cyclin-dependent kinases: Engines, clocks, and microprocessors, Annu. Rev. Cell Dev. Biol. 13, 261-291.
15. Malumbres, M.; Barbacid, M. (2001), To cycle or not to cycle: Acritical decision in cancer, Nature Rev. Cancer 1, 222-231 (2001).
16. Adon, A.M.; Zeng, X.; Harrison, M. K.; Sannem, S.; Kiyokawa, H.; Kaldis, P.; Saavedra, H. I. (2010), Cdk2 and Cdk4 regulate the centrosome cycle and are critical mediators of centrosome amplification in p53-null cells, Mol. Cell Biol. 30(3), 694-710.
17. Tillement, V.; Remy, M.-H.; Raynaud-Messina, B.; Mazzolini, L.; Haren, L.; Merdes, A. (2009), Spindle assembly defects leading to the formation of a monopolar mitotic apparatus, Biol. Cell 101, 1-11.
18. Malumbres, M.; Barbacid, M. (2005), Mammalian cyclin-dependent kinases, Trends Biochem. Sci. 30(11), 630-641.
19. Davies, S. P.; Reddy, H.; Caivano, M.; Cohen, P. (2000), Specificity and mechanism of action of some commonly used protein kinase inhibitors, Biochem. J. 351, 95-105.
20. Knockaert, M. et al. (2002), Pharmacological inhibitors of cyclin-dependent kinases, Trends Pharmacol. Sci. 23, 417-425.
21. McInnes, C. (2008), Progress in the evaluation of CDK inhibitors as anti-tumor agents, Drug Discov. Today 13, 875-881.
22. Huwe, A.; Mazitschek, R.; Giannis, A. (2003), Small molecules as inhibitors of cyclindependent kinases, Angew. Chem. 42(19), 2099-2201.
23. Nigg, E. A. (2001), Mitotic kinases as regulators of cell division and its checkpoints, Nature Rev. Mol. Cell. Biol. 2(1), 21-32.
24. Schmit, T. L.; Ahmad, N. (2007), Regulation of mitosis via mitotic kinases: New opportunities for cancer management, Mol. Cancer Ther. 6(7), 1920-1931.
25. Nasmyth, K. et al. (2002), Segregating sister genomes: The molecular biology of chromosome separation, Science 297, 559.
26. Kops, G. J.;Weaver,B. A.; Cleveland, D.W. (2005), On the road to cancer: Aneuploidy and the mitotic checkpoint, Nature Rev. Cancer, 5, 773-785.
27. Lampson, M. A.; Kapoor, T. M. (2005), The human mitotic checkpoint protein BubR1 regulates chromosome-spindle attachments, Nature Cell. Biol., 7, 93-98.
28. Hanks, S.; Coleman, K.; Reid, S.; Plaja, A.; Firth, H.; Fitzpatrick, D.; Kidd A.; Mehes, K.; Nash, R.; Robin, N.; et al. (2004), Constitutional aneuploidy and cancer predisposition caused by biallelic mutations in BUB1B, Nature Genet. 36, 1159-1161.
29. Matsuura, S.; Matsumoto, Y.; Morishima, K.; Izumi, H.; Matsumoto, H.; Ito, E.; Tsutsui, K.; Kobayashi, J.; Tauchi, H.; Kajiwara, Y.; et al. (2006), Monoallelic BUB1B mutations and defective mitotic-spindle checkpoint in seven families with premature chromatid separation (PCS) syndrome, Am. J. Med. Genet. 140, 358-367.
30. Baker, D. J.; Jeganathan, K. B.; Cameron, J. D.; Thompson, M.; Juneja, S.; Kopecka, A.; Kumar, R.; Jenkins, R. B.; deGroen, P. C.; Roche, P.; et al. (2004), BubR1 insufficiency causes early onset of aging-associated phenotypes and infertility in mice, NatureGenet. 36, 744-749.
31. Dai,W.;Wang, Q.; Liu, T.; Swamy, M.; Fang, Y.; Xie, S.; Mahmood, R.; Yang, Y. M.; Xu, M.; Rao, C. V. (2004), Slippage of mitotic arrest and enhanced tumor development in mice with BubR1 haploinsufficiency, Cancer Res. 64, 440-445.
32. Fisk, H. A.; Mattison, C. P.;Winey,M. (2004), A field guide to the Mps1 family of protein kinases, Cell Cycle. 3, 439-442.
33. Palframan,W. J.; Meehl, J. B.; Jaspersen, S. L.;Winey, M.; Murray,A.W. (2006), Anaphase inactivation of the spindle checkpoint, Science 313, 680-684.
34. Thompson, S. L.; Bakhoum, S. F.; Compton, D. A. (2010), Mechanisms of chromosomal instability, Curr. Biol. 20, 285-295.
35. Leng, M.; Chan, D. W.; Luo, H.; Zhu, C.; Qin, J.; Wang, Y. (2006), MPS1-dependent mitoticBLMphosphorylation is important for chromosome stability, Proc. Natl. Acad. Sci. USA 103, 11485-11490.
36. Poss, K. D.; Nechiporuk, A.; Stringer, K. F.; Lee, C.; Keating, M. T. (2004), Germ cell aneuploidy in zebrafish with mutations in the mitotic checkpoint gene mps1, Genes Dev. 18, 1527-1532.
37. Barr, F. A.; Sillje, H. H.; Nigg, E. A. (2004), Polo-like kinases and the orchestration of cell division, Nature Rev. Mol. Cell. Biol. 5, 429-440.
38. Strebhardt, K.; Ullrich, A. (2006), Targeting polo-like kinase 1 for cancer therapy, Nature Rev. Cancer 6, 321-330.
39. Neef, R.; Preisinger, C.; Stucliffe, J.; et al. (2003), Phosphorylation of mitotic kinesin-like protein 2 by polo-like kinase 1 is required for cytokinesis, J. Cell. Biol. 162, 863-875.
40. Hansen, D. V.; Loktev, A. V.; Ban, K. H.; et al. (2004), Plk1 regulates activation of the anaphase promoting complex by phosphorylating and triggering SCFbetaTrCP-dependent destruction of the APC Inhibitor Emi1, Mol. Biol. Cell 12, 5623-5634.
41. Golan, A.; Yudkovsky, Y.; Hershko, A. (2002), The cyclin-ubiquitin ligase activity of cyclosome/APC is jointly activated by protein kinases Cdk1-cyclin B and Plk, J. Biol. Chem. 277(18), 15552-15557.
42. Lane, H.; Nigg, E. A. (1996), Antibody microinjection reveals an essential role for human polo-like kinase 1 (Plk1) in the functional maturation of mitotic centrosomes, J. Cell. Biol. 135, 1701-1713.
43. do Carmo Avides, M.; Tavares, A.; Glover, D. M. (2001), Polo kinase and Asp are needed to promote the mitotic organizing activity of centrosomes, Nature Cell. Biol. 3, 421-424.
44. Arnaud, L.; Pines, J.; Nigg, E. A. (1998), GFP tagging reveals human polo-like kinase 1 at the kinetochore/centromere region of mitotic chromosomes, Chromosoma 107(6-7) 424-429.
45. Kraft, C.; Herzog, F.; Gieffers, C.; et al. (2003), Mitotic regulation of the human anaphasepromoting complex by phosphorylation, EMBO J. 22(24), 6598-6609.
46. Moshe, Y.; Boulaire, J.; Pagano, M.; et al. (2004), Role of Polo-like kinase in the degradation of early mitotic inhibitor 1, a regulator of the anaphase promoting complex/ cyclosome, Proc. Natl. Acad. Sci. USA 101(21), 7937-7942.
47. Alexandru, G.; Uhlmann, F.; Mechtler, K.; Poupart, M.-A.; Nasmyth, K. (2001), Phosphorylation of the cohesin subunit Scc1 by Polo/Cdc5 kinase regulates sister chromatid separation in yeast, Cell 105(4), 459-472.
48. Nigg, E. A. (1998), Polo-like kinases: Positive regulators of cell division from start to finish, Curr. Opin. Cell Biol. 10, 776-783.
49. Habedanck, R.; Stierhof, Y. D.;Wilkinson, C. J.; Nigg, E. A. (2005), The polo kinase Plk4 functions in centriole duplication, Nature Cell. Biol. 7(11), 1140-1146.
50. Giet, R.; Uzbekov, R.; Cubizolles, F.; et al. (1999), The Xenopus laevis aurora-related protein kinase pEg2 associates with and phosphorylates the kinesin-related protein XlEg5, J. Biol. Chem. 274(21), 15005-15013.
51. Giet, R.; McLean, D.; Descamps, S.; et al. (2002), Drosophila Aurora A kinase is required to localize D-TACCto centrosomes and to regulate astral microtubules, J. Cell Biol. 156(3), 437-451.
52. Adams, R. R.; Wheatley, S. P.; Gouldsworthy, A. M.; et al. (2000), INCENP binds the Aurora-related kinase AIRK2 and is required to target it to chromosomes, the central spindle and cleavage furrow, Curr. Biol. 10(17), 1075-1078.
53. Ohi, R.; Sapra, T.; Howard, J.; et al. (2004), Differentiation of cytoplasmic and meiotic spindle assembly MCAK functions by Aurora B-dependent phosphorylation, Mol. Biol. Cell 15(6), 2895-2906.
54. Girdler, F.; Gascoigne, K. E.; Eyers, P. A.; Hartmuth, S.; Crafter, C.; Foote, K. M.; Keen, N. J.;Taylor, S. S. (2006), Validating AuroraBas an anti-cancer drug target, J. Cell Sci. 119, 3664-3675.
55. Hu, H. M.; Chuang, C. K.; Lee, M. J.; et al. (2000), Genomic organization, expression, and chromosome localization of a third aurora-related kinase gene, Aie1, DNA Cell Biol. 19(11), 679-688.
56. Fry, A. M. (2002), The Nek2 protein kinase: A novel regulator of centrosome structure, Oncogene 21, 6184-6194.
57. Prigent, C.; Glover, D. M.; Giet, R. (2005), Drosophila Nek2 protein kinase knockdown leads to centrosome maturation defects while overexpression causes centrosome fragmentation and cytokinesis failure, Exp. Cell Res. 303(1), 1-13.
58. Fry, A. M.; Mayor, T.; Meraldi, P.; et al. (1998), C-Nap1, a novel centrosomal coiled-coil protein and candidate substrate of the cell cycle-regulated protein kinase Nek2, J. Cell Biol. 141(7), 1563-1574.
59. Hayward, D. G.; Fry, A. M. (2006), Nek2 kinase in chromosome instability and cancer, Cancer Lett. 237, 155-166.
60. Rapley, J.; Baxter, J. E.; Blot, J.;Wattam, S. L.; Casenghi, M.; Meraldi, P.; Nigg, E. A.; Fry, A. M. (2005), Coordinate regulation of the mother centriole component Nlp by Nek2 and Plk1 protein kinases, Mol. Cell. Biol. 25, 1309-1324.